Larvol Delta - A-Phase-II-Study-of-Pemigatinib-Plus-Durvalumab-in-Previously-Treated-Advanced-Intrahepatic-Cholangiocarcinoma-Patients-With-FGFR2-Fusion-or-Rearrangement

Imfinzi (durvalumab) - AstraZeneca

Pemazyre (pemigatinib) - Incyte

http://clinicaltrials.gov/ct2/show/NCT06728410

Sep 3, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next